Cargando…
NSAID use and somatic exomic mutations in Barrett’s esophagus
BACKGROUND: Use of aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) has been shown to protect against tetraploidy, aneuploidy, and chromosomal alterations in the metaplastic condition Barrett’s esophagus (BE) and to lower the incidence and mortality of esophageal adenocarcinoma (EA)....
Autores principales: | Galipeau, Patricia C., Oman, Kenji M., Paulson, Thomas G., Sanchez, Carissa A., Zhang, Qing, Marty, Jerry A., Delrow, Jeffrey J., Kuhner, Mary K., Vaughan, Thomas L., Reid, Brian J., Li, Xiaohong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5830331/ https://www.ncbi.nlm.nih.gov/pubmed/29486792 http://dx.doi.org/10.1186/s13073-018-0520-y |
Ejemplares similares
-
Correction to: NSAID use and somatic exomic mutations in Barrett’s esophagus
por: Galipeau, Patricia C., et al.
Publicado: (2019) -
NSAIDs Modulate Clonal Evolution in Barrett's Esophagus
por: Kostadinov, Rumen L., et al.
Publicado: (2013) -
Within‐patient phylogenetic reconstruction reveals early events in Barrett’s Esophagus
por: Smith, Lucian P., et al.
Publicado: (2020) -
Somatic whole genome dynamics of precancer in Barrett’s esophagus reveals features associated with disease progression
por: Paulson, Thomas G., et al.
Publicado: (2022) -
p16 Mutation Spectrum in the Premalignant Condition Barrett's Esophagus
por: Paulson, Thomas G., et al.
Publicado: (2008)